Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform ...

Fintel reports that on January 30, 2025, Oppenheimer initiated coverage of Alumis (NasdaqGS:ALMS) with a Outperform ...

Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.

Oppenheimer assumed coverage on shares of Alumis (NASDAQ:ALMS – Free Report) in a research note published on Thursday morning, MarketBeat.com reports. The firm issued an outperform rating and a $32.00 ...

Peace prospects look bleak in Myanmar as a civil war rages despite international pressure on the military four years after it ...

Despite their continuous efforts against mendicancy, the Cebu City Anti-Mendicancy Office revealed that the deeply-ingrained attitude towards mendicancy remains the biggest challenge they face in ...

There’s a lot to be optimistic about in the Materials sector as 2 analysts just weighed in on Alumis Inc. (ALMS – Research Report) and Corning ...

Alumis (ALMS) stock gains as Oppenheimer initiates coverage with an Outperform recommendation, citing a valuation disconnect. Read more here.

Millions dined in their restaurants worldwide, getting a taste of Malaysia supplied by a sprawling conglomerate that claimed ...

Alumis Inc. (NASDAQ:ALMS – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight brokerages that are presently covering the stock, Marketbeat reports. Six analysts have ...

JAKARTA: Indonesia’s National Alms Agency (Baznas) aims to collect and mobilise Rp750 billion (US$46 million) in charitable funds to reconstruct a range of public facilities in Palestine, including ...

Alumis (ALMS) announced that it has strengthened its leadership team with key appointments to support its transition to a late-stage company.